Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis
- Type
- Retraction
- Notice date
- 11/19/2021 0:00
- Journal
- ACS Omega
- Publisher
- American Chemical Society (ACS)
- Notice DOI
- 10.1021/acsomega.1c06159
- Original paper DOI
- 10.1021/acsomega.9b04357